Studies causes of polycystic ovary syndrome and related pregnancy problems
Observes women with polycystic ovary syndrome to study its underlying causes and related problems.
Key facts
- Who runs it
- University of Oxford
- Where
- Oxford, United KingdomSee the site
- Trial code
- Registry title
- Reproductive Endocrinology Oxford Study (RepOx)
- Status
- Recruiting
- People taking part
- 1,175 people, planned
- Started
- 21 Oct 2021
- Expected to end
- 1 Sept 2028
- Type of study
- Observational, 10 groups
- Record updated
- 4 January 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 16 to 45 with or under investigation for polycystic ovary syndrome (PCOS). It also enrols women with repeated miscarriage, pregnancy complications, and comparison groups.
- Age
- 16 to 45 years (18 to 45 years for women having IVF)
- Sex
- Women only
- Disease stage
- Several groups: PCOS (or under investigation for it), at least two miscarriages, gestational diabetes or intrahepatic cholestasis of pregnancy from 28 weeks of pregnancy, and comparison groups without these conditions.
- Biomarker or test result
- Groups with gestational diabetes or cholestasis of pregnancy need raised blood glucose or raised liver enzyme (ALT) and bile acid levels, as listed in the record.
Main reasons for not taking part
- Cannot read or understand written or spoken English
- Currently in a clinical trial of an investigational medicine
- Having surgery because of a possible cancer
- Another condition with too much androgen, such as congenital adrenal hyperplasia, androgen-secreting tumours, Cushing syndrome or hyperprolactinemia
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- ● General Criteria for all groups; Participant is willing and able to give informed consent for participation in the study; Female, aged between 16 and 45 years of age. As IVF is not undertaken in women less that 18 years, this group will between 18 and 45 years o; ● PCOS (Group 1, 2 and 3); Currently under investigation for or having diagnosis of PCOS having displayed one or more of the following: Hyperandrogenism, Ovulation Dysfunction and Polycystic ovaries on ultrasound (known as the Rotterdam criteria); ● PCOS Controls (Group 4 and 5); Patients under gynaecological investigation or having assisted reproduction; Exhibit no features of PCOS; ● Miscarriage Group (Group 6); Have had at least two previous miscarriages; Recruited at any time after their second menstrual cycle following a miscarriage; ● Miscarriage Controls (Group 7); Patients will have had zero or no more than one miscarriage and having fertility investigations; ● Pregnant GDM (Group 8); Pregnant women at least 28 weeks gestation with :; 1) A fasting plasma glucose of 5.1mmol/L or above or; 2) A 1 hr plasma glucose of 10mmol/L or; 3) A 2-hr plasma glucose level of 8.5mmol/L or above; ● Pregnant ICP (Group 9); Women at least 28 weeks gestation with :; Raised ALT or raised bile acids in the context of pruritus with no rash; ALT (>32iu/l) and bile acids (>14micromol/l) Pregnant Control (Group 10); Pregnant women at least 28 weeks gestation with no diagnosis of GDM or ICP
Who cannot take part
- For all groups - The participant may not enter the study if ANY of the following apply; Unable to read, or to understand written or spoken English; Currently involved in any Clinical Trial of an Investigational Medicinal Product (CTIMP); Undergoing surgery because of a possible cancer diagnosis; Diagnosis of other androgen excess disorders such as Congenital Adrenal Hyperplasia (CAH), Androgen Secreting tumours, Cushing syndrome, or Hyperprolactinemia
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 45 years old?
Where in United Kingdom
- Nuffield Department Women's and Reproductive HealthOxford, United KingdomContact: OSPREA -Study Research MidwivesTaking people
About the trial
What the trial wants to find out
This is a prospective observational study that aims to identify the underlying mechanisms of PolyCystic Ovarian Syndrome (PCOS) and associated comorbidities such as subfertility, miscarriage; and pregnancy complications such as gestational diabetes mellitus and Intrahepatic cholestasis of pregnancy (ICP). This will be achieved through cross-sectional observation and laboratory analyses.
The 10 groups in the trial
- PCOS
No intervention.
- PCOS surgery
No intervention
- Surgery control
No intervention
- IVF PCOS
No intervention
- IVF control
No intervention
- Investigations, fertility PCOS
No intervention
- Investigations, fertility control
No intervention
- Pregnancy - gestational diabetes mellitus
No intervention
- Pregnancy - Intrahepatic cholestasis of pregnancy
No intervention
- Pregnancy - control
No intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Reproductive Endocrinology Oxford Study (RepOx)
- Plain-language title
- Studies causes of polycystic ovary syndrome and related pregnancy problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05177562, who can take part
- Record updated
- 4 January 2022